FR2639947B1 - Derives peptidiques - Google Patents

Derives peptidiques

Info

Publication number
FR2639947B1
FR2639947B1 FR8915993A FR8915993A FR2639947B1 FR 2639947 B1 FR2639947 B1 FR 2639947B1 FR 8915993 A FR8915993 A FR 8915993A FR 8915993 A FR8915993 A FR 8915993A FR 2639947 B1 FR2639947 B1 FR 2639947B1
Authority
FR
France
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8915993A
Other languages
English (en)
French (fr)
Other versions
FR2639947A1 (fr
Inventor
Albert Rainer
Eric P Krenning
Steven W J Lamberts
Pless Janos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828364A external-priority patent/GB8828364D0/en
Priority claimed from GB898916115A external-priority patent/GB8916115D0/en
Priority claimed from GB898916761A external-priority patent/GB8916761D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2639947A1 publication Critical patent/FR2639947A1/fr
Application granted granted Critical
Publication of FR2639947B1 publication Critical patent/FR2639947B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8915993A 1988-12-05 1989-12-04 Derives peptidiques Expired - Lifetime FR2639947B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888828364A GB8828364D0 (en) 1988-12-05 1988-12-05 Improvements in/relating to organic compounds
GB898916115A GB8916115D0 (en) 1989-07-13 1989-07-13 Improvements in or relating to organic compounds
GB898916761A GB8916761D0 (en) 1989-07-21 1989-07-21 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
FR2639947A1 FR2639947A1 (fr) 1990-06-08
FR2639947B1 true FR2639947B1 (fr) 1995-04-21

Family

ID=27264222

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8915993A Expired - Lifetime FR2639947B1 (fr) 1988-12-05 1989-12-04 Derives peptidiques

Country Status (24)

Country Link
JP (2) JP2726320B2 (pt)
KR (1) KR0156541B1 (pt)
AT (1) AT403476B (pt)
AU (1) AU633859B2 (pt)
BE (1) BE1002296A5 (pt)
CA (1) CA2004532C (pt)
CH (1) CH678329A5 (pt)
DE (1) DE3991505B4 (pt)
DK (1) DK175338B1 (pt)
ES (1) ES2023533A6 (pt)
FI (1) FI102540B1 (pt)
FR (1) FR2639947B1 (pt)
GB (1) GB2225579B (pt)
HK (1) HK189995A (pt)
HU (2) HUT53375A (pt)
IE (1) IE62091B1 (pt)
IL (1) IL92534A (pt)
LU (1) LU87633A1 (pt)
MY (1) MY106120A (pt)
NL (1) NL194828C (pt)
PT (1) PT92487B (pt)
SA (1) SA96160495B1 (pt)
SE (1) SE508799C2 (pt)
WO (1) WO1990006949A2 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3845000C2 (de) * 1987-07-10 1998-11-19 Novartis Ag Anwendung von Octreotid zur Behandlung von Brustkrebs
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
ATE181240T1 (de) * 1991-02-08 1999-07-15 Biomeasure Inc Verwendung von somatostatinanalogen zur behandlung von melanomen
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
WO1992021383A1 (en) * 1991-06-03 1992-12-10 Mallinckrodt Medical, Inc. Radiolabelled somatostatin derivatives, their preparation and use
DE69231469T2 (de) * 1991-08-29 2001-01-25 Mallinckrodt Medical Inc Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
AU683833B2 (en) * 1992-01-03 1997-11-27 Rhomed Incorporated Protein- and peptide-metal ion pharmaceutical applications
ATE203417T1 (de) * 1992-02-05 2001-08-15 Mallinckrodt Inc Radioaktiv markierte somatostatin
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
CA2131315A1 (en) * 1992-03-25 1993-09-30 Geert J. Ensing Method of intraoperatively detecting and locating tumoral tissues
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
EP0607103A3 (en) * 1993-01-12 1997-07-09 Sandoz Ltd Somatostatin analogs containing chelating groups and their radiolabeled compositions.
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2154667A1 (en) * 1993-02-02 1994-08-18 Linda M. Gustavson Directed biodistribution of small molecules
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
EP0720621B1 (en) * 1993-06-23 2001-02-07 Diatide, Inc. Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
GB9708265D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
FI965181A (fi) * 1996-12-20 1998-06-21 Map Medical Technologies Oy Polyalkoholi-peptidijohdannaiset
US6630570B1 (en) 1999-04-09 2003-10-07 Insitut für Diagnostikforschung GmbH Short-chain peptide-dye conjugates as contrast media for optical diagnosis
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
US7175953B2 (en) 1999-04-09 2007-02-13 Institute Fuer Diagnostik Forschung Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
CZ20032872A3 (cs) 2001-04-23 2005-01-12 Mallinckrodt Inc. Peptický ligand, který váže receptor somatostatinu
CN100475271C (zh) 2003-08-20 2009-04-08 加利福尼亚大学董事会 具有抑制生长激素释放活性的促生长素抑制素类似物
JP5395327B2 (ja) * 2003-09-17 2014-01-22 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 機構ベースの標的化した膵臓β細胞画像化および治療
EP2067786A1 (en) 2007-12-07 2009-06-10 ITALFARMACO S.p.A. Novel non selective analogs of somatostatin
WO2014081655A1 (en) 2012-11-21 2014-05-30 Serene Oncology, Llc Tin-1 17m comprising somatostatin receptor binding compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
DE3511206A1 (de) * 1985-03-28 1986-10-09 Sandoz-Patent-GmbH, 7850 Lörrach Neue polypeptidderivate, ihre herstellung und pharmazeutische praeparate, welche diese polypeptidderivate enthalten
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
AU593611B2 (en) * 1986-02-14 1990-02-15 Nihon Medi-Physics Co., Ltd. High molecular compounds having amino groups, and their utilization
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
CH679045A5 (pt) * 1987-06-29 1991-12-13 Sandoz Ag
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
FR2638968B1 (fr) * 1988-11-11 1994-10-07 Sandoz Sa Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives

Also Published As

Publication number Publication date
DK612689D0 (da) 1989-12-05
HUT53375A (en) 1990-10-28
BE1002296A5 (fr) 1990-11-20
NL194828C (nl) 2003-04-03
GB2225579B (en) 1993-03-17
AU633859B2 (en) 1993-02-11
CA2004532A1 (en) 1990-06-05
GB2225579A (en) 1990-06-06
LU87633A1 (fr) 1991-09-18
GB8927255D0 (en) 1990-01-31
PT92487A (pt) 1990-06-29
JP3686503B2 (ja) 2005-08-24
AU4587189A (en) 1990-06-14
KR900009697A (ko) 1990-07-05
MY106120A (en) 1995-03-31
FI895809A0 (fi) 1989-12-04
CA2004532C (en) 2000-02-22
HU896359D0 (en) 1990-02-28
IE62091B1 (en) 1994-12-14
DE3991505B4 (de) 2006-04-20
WO1990006949A3 (en) 1990-07-26
AT403476B (de) 1998-02-25
SE8904087D0 (sv) 1989-12-04
ES2023533A6 (es) 1992-01-16
HK189995A (en) 1995-12-29
IL92534A (en) 1994-06-24
NL8902981A (nl) 1990-07-02
FI102540B (fi) 1998-12-31
SE8904087L (sv) 1991-06-05
ATA901789A (de) 1997-07-15
KR0156541B1 (ko) 1998-10-15
WO1990006949A2 (en) 1990-06-28
SA96160495B1 (ar) 2006-08-23
FR2639947A1 (fr) 1990-06-08
JPH1095737A (ja) 1998-04-14
CH678329A5 (pt) 1991-08-30
DK612689A (da) 1990-06-06
IE893866L (en) 1990-06-05
FI102540B1 (fi) 1998-12-31
HU211468A9 (en) 1995-11-28
SE508799C2 (sv) 1998-11-09
NL194828B (nl) 2002-12-02
DK175338B1 (da) 2004-08-30
JPH02184698A (ja) 1990-07-19
PT92487B (pt) 1996-01-31
JP2726320B2 (ja) 1998-03-11

Similar Documents

Publication Publication Date Title
FR2639947B1 (fr) Derives peptidiques
DK163689A (da) Peptidderivater
DK22588D0 (da) Peptidderivater
FI941398A (fi) Modifioituja peptidijohdannaisia
DE69230727D1 (de) Neuartige peptidderivate
DK532787A (da) Peptidderivater
DK540289D0 (da) Protein
DE68925161D1 (de) Alkylavermectin-Derivate
DE68927948D1 (de) Trehalosderivate
DK375789D0 (da) Peptidderivater
DK371989A (da) Amidderivater
DK19789A (da) Dehydrocholcalciferolderivater
DK197989A (da) Peptidanaloger
FR2639044B1 (fr) Derives de la butynylamine
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK301889D0 (da) Peptidderivater
DK177789A (da) Peptidderivater
DK4390A (da) Peptidderivater
KR900700503A (ko) 펩티드
DE3824433A1 (de) Fluorcyclopropyl-derivate
DK160389A (da) Aryldionderivater
DK657189A (da) Peptidderivater
ATA155589A (de) Mitomycinphosphat-derivate
DK679488A (da) Peptidderivater
DK171489D0 (da) Peptidderivater

Legal Events

Date Code Title Description
TP Transmission of property